Results

Total Results: 425 records

Showing results for "laboratory".

21. Appendix Table B-3. Observational Studies of Masks in Healthcare Settings (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
    February 01, 2020 - respiratory therapist 10.7% radiology technologist 6.1% housekeeper 4.2% personal service assistant 2.2% laboratory … 0.18 (0.06 to 0.53)* Not reported Not reported Potential recall bias; SARS-1 diagnosis did not require laboratory … 54.2% 26–40 years old, 10.8% >50 years old 76% 31.5% doctor 49.2% nurse 7.3% health attendant 5.0% laboratory … recall bias; no control for confounding; controls not matched other than exposure to patients with SARS; laboratory

22. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
    January 01, 2009 - technology assessment should begin by establishing the capability of the technology under ideal or laboratory … Trials in humans take place only after drugs have been tested thoroughly in the laboratory in animal … The process also cycles and moves “up the rungs” from laboratory to applied research and, ultimately … Conceptual framework for evaluating laboratory tests: case-finding in ambulatory patients. … Evaluating laboratory diagnostic tests. BMJ 2008;336:569-570. 29. Price CP, Christenson RH.

23. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
    January 01, 2009 - technology assessment should begin by establishing the capability of the technology under ideal or laboratory … Trials in humans take place only after drugs have been tested thoroughly in the laboratory in animal … The process also cycles and moves “up the rungs” from laboratory to applied research and, ultimately … Conceptual framework for evaluating laboratory tests: case-finding in ambulatory patients. … Evaluating laboratory diagnostic tests. BMJ 2008;336:569-570. 29. Price CP, Christenson RH.

24. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
    September 08, 2011 - three procalcitonin quantitative assays that are commercially available, but the optimal approach to laboratory … our understanding of procalcitonin is still evolving, clinicians have already begun to request laboratories … infection, what are the effects of procalcitonin measurement plus clinical signs/symptoms and other laboratory … Procalcitonin for the clinical laboratory: a review. Pathology 2007;39(4):383-90. 10. … Therapy (type, duration) based on clinical signs/symptoms (e.g., fever, pain), and other laboratory

25. Appendix Table B-1. RCTs of Masks (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
    April 09, 2020 - Clinical Respiratory Illness - Results Influenzalike Illness - Definition Influenzalike Illness - Results Laboratory-Confirmed … Viral Respiratory Illness – Definition Laboratory-Confirmed Viral Respiratory Illness – Results Laboratory-Confirmed … Influenza – Definition Laboratory-Confirmed Influenza – Results Laboratory-Confirmed Coronavirus Infection … – Definition Laboratory-Confirmed Coronavirus Infection – Results Work-Related Outcomes – Definition … 568) General discomfort: 35.1% (397/1130) overall Breathing problems: 18.3% (207/1130) overall 85% of laboratory

26. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
    April 09, 2020 - Clinical Respiratory Illness – Results Influenzalike Illness – Definition Influenzalike Illness – Results Laboratory-Confirmed … Viral Respiratory Illness – Definition Laboratory-Confirmed Viral Respiratory Illness – Results Laboratory-Confirmed … Influenza – Definition Laboratory-Confirmed Influenza – Results Laboratory-Confirmed Coronavirus Infection … – Definition Laboratory-Confirmed Coronavirus Infection – Results Work-Related Outcomes – Definition … 568) General discomfort: 35.1% (397/1130) overall Breathing problems: 18.3% (207/1130) overall 85% of laboratory

27. Masks-Appendix-Table-B-1-Version-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
    April 09, 2020 - Clinical Respiratory Illness – Results Influenzalike Illness – Definition Influenzalike Illness – Results Laboratory-Confirmed … Viral Respiratory Illness – Definition Laboratory-Confirmed Viral Respiratory Illness – Results Laboratory-Confirmed … Influenza – Definition Laboratory-Confirmed Influenza – Results Laboratory-Confirmed Coronavirus Infection … – Definition Laboratory-Confirmed Coronavirus Infection – Results Work-Related Outcomes – Definition … 568) General discomfort: 35.1% (397/1130) overall Breathing problems: 18.3% (207/1130) overall 85% of laboratory

28. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
    April 09, 2020 - Clinical Respiratory Illness – Results Influenzalike Illness – Definition Influenzalike Illness – Results Laboratory-Confirmed … Viral Respiratory Illness – Definition Laboratory-Confirmed Viral Respiratory Illness – Results Laboratory-Confirmed … Influenza – Definition Laboratory-Confirmed Influenza – Results Laboratory-Confirmed Coronavirus Infection … – Definition Laboratory-Confirmed Coronavirus Infection – Results Work-Related Outcomes – Definition … 568) General discomfort: 35.1% (397/1130) overall Breathing problems: 18.3% (207/1130) overall 85% of laboratory

29. Masks-Surveillance-2-Appendix-Table-A-3 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-3.xlsx
    March 23, 2020 - respiratory therapist 10.7% radiology technologist 6.1% housekeeper 4.2% personal service assistant 2.2% laboratory … 0.18 (0.06 to 0.53)* Not reported Not reported Potential recall bias; SARS-1 diagnosis did not require laboratory … 34.9% <26 years of age, 54.2% 26-40, 10.8% >50 76% 31.5% doctor 49.2% nurse 7.3% health attendant 5.0% laboratory … recall bias; no control for confounding; controls not matched other than exposure to patients with SARS; laboratory

30. Masks-Appendix-Table-B-3-Surveillance-Report (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-3-surveillance-report.xlsx
    February 01, 2020 - respiratory therapist 10.7% radiology technologist 6.1% housekeeper 4.2% personal service assistant 2.2% laboratory … 0.18 (0.06 to 0.53)* Not reported Not reported Potential recall bias; SARS-1 diagnosis did not require laboratory … 34.9% <26 years of age, 54.2% 26-40, 10.8% >50 76% 31.5% doctor 49.2% nurse 7.3% health attendant 5.0% laboratory … Not reported Potential recall bias; controls not matched other than exposure to patients with SARS; laboratory

31. Masks-Appendix-Table-B-3-Version-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-3-version-2.xlsx
    February 01, 2020 - respiratory therapist 10.7% radiology technologist 6.1% housekeeper 4.2% personal service assistant 2.2% laboratory … 0.18 (0.06 to 0.53)* Not reported Not reported Potential recall bias; SARS-1 diagnosis did not require laboratory … 34.9% <26 years of age, 54.2% 26-40, 10.8% >50 76% 31.5% doctor 49.2% nurse 7.3% health attendant 5.0% laboratory … Not reported Potential recall bias; controls not matched other than exposure to patients with SARS; laboratory

32. Disposition of Comments Report for Interventions for Feeding and Nutrition in Cerebral Palsy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
    March 20, 2013 - Public reviwer (Abbott Laboratories) Executive Summary Page ES-3: We agree with the statement … Public reviwer (Abbott Laboratories) Introduction We also agree with the comment that “caregiver … Public reviwer (Abbott Laboratories) Introduction We agree that “no uniform decision pathway for … Public reviwer (Abbott Laboratories) General Page ES-11 and Results Section Page 27 (Key Question … Public reviwer (Abbott Laboratories) General While no studies were identified in this review that

33. S149 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - Results from laboratory evaluations were available on a subset of the enrollees depending on the diagnostic … We did not include laboratory data in the propensity models because laboratory data were only available … We applied our methods to this subset having laboratory data, and included Hba1c and glu- cose in the … In future work we will further investigate whether the inclusion of laboratory data improves the fit … of diabetes, this will have broad implications as most observational datasets do not have laboratory

34. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
    March 07, 2012 - While this is still a standard test, it is highly subjective with results varying from one laboratory … Indeed, in many reference laboratories, EIA is the main test that is used to screen. … The ANA test is performed by hundreds of different laboratories across the United States. … March 7, 2012 10 Commentator & Affiliation Section Comment Response involved many different laboratories … Many of the national laboratories screen for ANAs using solid phase assays.

35. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - the United States are the FDA and the Centers for Medicare and Medicaid Services under the Clinical Laboratory … The FDA has jurisdiction over both laboratory developed tests (LDTs) for use in an in- house laboratory … www.effectivehealthcare.ahrq.gov/ Source: www.effectivehealthcare.ahrq.gov Published Online: March 13, 2012 laboratories … As a result, GEPs marketed as LDTs may enter the U.S. market with analytical validation under laboratory … The clinical experts will come from the disciplines of medical oncology, surgical oncology, laboratory

36. S143 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - outpatient and inpatient services including ambulatory care, approved specialists and outside referrals, laboratory … Lipoprotein measures (LDL, HDL, and TG) were assumed to be valid for up to 6 months from the date of the laboratory … electrocardiograms or depression) and substantial difference with respect to other variables (such as lipid-related laboratory … cardiovascular disease-related hospitalizations in the past year 0.46 0.31 �0.01 0.40 0.39 0.79 Mean no. laboratory … We found that measures of healthcare utilization (in- tensities of lipid-related laboratory testing,

37. Kidney-Stone-Prevention Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
    June 15, 2011 - Evaluation of Nephrolithiasis Clinical guidelines recommend laboratory evaluation of patients who … However, the value of baseline and followup laboratory evaluations in patients with nephrolithiasis … Controversies include whether pretreatment laboratory test results predict effectiveness of treatment … on final health outcomes; whether treatment tailored to pretreatment laboratory results is associated … – For the subquestion about whether treatment effectiveness differs according to patient baseline laboratory

38. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
    June 24, 2014 - What clinical, imaging, laboratory, and anatomic characteristics are associated with improved or worse

39. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - of the most popular methods for currently measuring tacrolimus, there is no standardization between laboratories … comparisons (e.g., inter-laboratory agreement, measurement reproducibility) Intermediate-term clinical … Imprecision in laboratory results, between and within labs, will also present a challenge to applying … ' OR 'inter-laboratory') NEAR/2 (agreement OR measurement OR reproducibility)) 12 RCT or controlled … different operators, different instruments, different reagent lots, different days of the week, different laboratories

40. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
    May 18, 2011 - Available fecal DNA tests are instead offered as a direct-to-consumer laboratory-developed test; such … tests are currently regulated by the Centers for Medicare and Medicaid Services under the Clinical Laboratory … manufacturers and the public about how it should develop a consistent, reasonable, and fair approach for laboratory-developed … being conducted, including the gene mutations/expression analyzed, the assay characteristics and laboratory … Abbreviations CLIA = Clinical Laboratory Improvement Amendments CRC = Colorectal Cancer CT